From: Circulating CTRP5 in rheumatoid arthritis: an exploratory biomarker study
Treatment | Number of RA patients | Percent of RA patients (%) |
---|---|---|
Hydroxychloroquine | 18 | ~ 40 |
Methotrexate | 38 | ~ 83 |
Sulfasalazine | 22 | ~ 48 |
Prednisolone | 36 | ~ 79 |
AZARAM | 1 | ~ 2 |
Biologic Treatment | 1 | ~ 2 |
No Treatment | 2 | ~ 4 |